Press release
Paget's Disease Market Insights and Future Outlook
Paget's Disease Market
Paget's disease of bone is a chronic skeletal disorder that disrupts the normal bone remodeling process, leading to enlarged and weakened bones. The condition primarily affects older adults and can cause bone pain, deformities, and fractures. Increasing awareness, diagnostic advancements, and availability of bisphosphonate-based therapies are driving the global Paget's disease market.
According to Exactitude Consultancy, the market is projected to grow from USD 2.1 billion in 2024 to USD 4.1 billion by 2034, at a CAGR of 6.9% during the forecast period.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71005
Market Overview
• Market Size (2024): USD 2.1 billion
• Market Forecast (2034): USD 4.1 billion
• CAGR (2025-2034): 6.9%
Key Growth Drivers
• Rising prevalence among aging populations in Europe and North America.
• Advances in diagnostic imaging such as X-rays, bone scans, and CT.
• Widespread use of bisphosphonates for bone health management.
• Increasing focus on patient-centric treatment and rehabilitation.
Challenges
• Low disease awareness in emerging economies.
• Limited treatment options beyond bisphosphonates.
• Adverse effects of long-term drug use.
Segmentation Analysis
By Treatment Type
• Bisphosphonates (zoledronic acid, alendronate, risedronate)
• Pain management drugs (NSAIDs, analgesics)
• Surgical interventions (fracture repair, joint replacement)
• Others
By Diagnosis
• Blood tests (alkaline phosphatase levels)
• Imaging (X-rays, MRI, CT scans, bone scans)
• Others
By End User
• Hospitals
• Specialty clinics
• Research institutes
• Homecare
Segmentation Summary:
The bisphosphonate therapy segment dominates due to its efficacy in controlling bone turnover, while diagnostic imaging is vital for early detection and disease management.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71005/paget-s-disease-market
Regional Analysis
• North America
Leading market due to higher disease prevalence, advanced healthcare systems, and strong adoption of bisphosphonates.
• Europe
Significant share owing to large elderly population and well-developed healthcare infrastructure.
• Asia-Pacific
Fastest-growing region, with improving healthcare access and increasing focus on bone health in aging populations.
• Middle East & Africa
Slow but growing adoption of diagnostic and therapeutic solutions.
• Latin America
Gradual expansion due to healthcare modernization and rising awareness.
Regional Summary:
While North America and Europe dominate the market due to higher prevalence, Asia-Pacific is expected to be the most dynamic region over the next decade.
Market Dynamics
Growth Drivers
• Expansion of diagnostic technologies for early detection.
• Increasing use of minimally invasive surgeries for deformities.
• Rising R&D in novel drug formulations for bone remodeling.
Challenges
• Limited awareness in low-income countries.
• Dependence on long-term pharmacological treatment.
Latest Trends
• Research into genetic risk factors associated with Paget's disease.
• Development of targeted therapies with fewer side effects.
• Integration of digital health platforms for patient monitoring.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71005
Competitor Analysis
Key Players
• Novartis AG
• Amgen Inc.
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Bristol Myers Squibb
• Bayer AG
• Eli Lilly and Company
Competitive Summary:
The market is moderately competitive, with leading pharmaceutical firms focusing on bisphosphonate R&D, patient support programs, and advanced diagnostic integration.
Conclusion
The Paget's Disease Market is projected to grow from USD 2.1 billion in 2024 to USD 4.1 billion by 2034, at a CAGR of 6.9%. Rising awareness, aging populations, and better diagnostic tools will continue to support steady growth.
Key Takeaways:
• CAGR of 6.9% through 2034.
• Bisphosphonates remain the cornerstone of treatment.
• North America and Europe lead, while Asia-Pacific is the fastest-growing region.
• Innovations in diagnostics and therapies are opening new opportunities.
This report is also available in the following languages : Japanese (パジェット病市場), Korean (파제트병 시장), Chinese (佩吉特氏病市场), French (Marché de la maladie de Paget), German (Markt für Morbus Paget), and Italian (Mercato della malattia di Paget), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71005
Our More Reports:
Warm Autoimmune Hemolytic Anemia Market
https://exactitudeconsultancy.com/reports/71295/warm-autoimmune-hemolytic-anemia-market
Anemia Market
https://exactitudeconsultancy.com/reports/71296/anemia-market
Anemia in Elderly Market
https://exactitudeconsultancy.com/reports/71297/anemia-in-elderly-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
IRFAN TAMBOLI
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Paget's Disease Market Insights and Future Outlook here
News-ID: 4154314 • Views: …
More Releases from Exactitude Consultancy
Rheumatoid Arthritis (RA) Patient Pool Analysis Market to Set Phenomenal Growth …
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily affects joints, causing inflammation, pain, stiffness, and progressive joint damage. Beyond musculoskeletal effects, RA can impact the cardiovascular system, lungs, and overall quality of life. Affecting approximately 1% of the global population, RA is among the most prevalent autoimmune diseases, with significant social and economic burdens.
Over the past two decades, the RA treatment landscape has transformed with the introduction of…
Liver Fibrosis Patient Pool Analysis Market Set to Witness Significant Growth by …
Introduction
Liver fibrosis is a progressive pathological condition characterized by excessive accumulation of extracellular matrix proteins, mainly collagen, in the liver. It represents the body's wound-healing response to chronic liver damage caused by factors such as viral hepatitis, alcoholic liver disease, non-alcoholic steatohepatitis (NASH), autoimmune disorders, and metabolic conditions. If untreated, liver fibrosis can progress to cirrhosis and hepatocellular carcinoma, contributing significantly to global morbidity and mortality.
With the global burden of…
Hypoparathyroidism Patient Pool Analysis Market 2025-2034 Business Outlook, Crit …
Introduction
Hypoparathyroidism is a rare endocrine disorder characterized by insufficient secretion of parathyroid hormone (PTH), leading to hypocalcemia, hyperphosphatemia, and impaired bone and renal function. Most cases are caused by surgical removal of the parathyroid glands during thyroidectomy, while others result from autoimmune conditions, genetic mutations, or idiopathic causes.
For decades, treatment relied on conventional calcium and vitamin D supplementation, which manage symptoms but do not replace missing PTH. The approval of…
Alcoholic Liver Disease (ALD) Patient Pool Analysis Market New Product Developme …
Introduction
Alcoholic liver disease (ALD) is one of the leading causes of chronic liver disorders worldwide, directly associated with long-term excessive alcohol consumption. ALD manifests across a spectrum ranging from fatty liver (steatosis) to alcoholic hepatitis, fibrosis, cirrhosis, and ultimately hepatocellular carcinoma. The rising burden of alcohol misuse, coupled with changing lifestyle patterns, is driving increased incidence and mortality linked to ALD.
With no universally approved targeted therapies for ALD, treatment strategies…
More Releases for Paget
Paget Disease Treatment Market Anticipated To Witness Robust Growth, Surpassing …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Current Paget Disease Treatment Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent growth in the market size for Paget's disease treatment. It's projected to rise from $2.12 billion in 2024 to $2.21 billion in 2025, with a compound annual growth rate (CAGR)…
Paget Disease Treatment Market Detailed in New Research Report - Amgen Inc., Nov …
Paget Disease Treatment Market Snapshot
The Paget's Disease Treatment Market is projected to reach USD 1.32 billion by 2032, growing at a CAGR of 5.8% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Paget Disease Treatment Market Research Report, delivering a detailed examination of the U.S. Paget Disease Treatment Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving…
Paget Disease Treatment Market Anticipated To Witness Robust Growth, Surpassing …
The Paget Disease Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Paget Disease Treatment Market Size and Its Estimated Growth Rate?
The market for Paget's disease treatments has been progressively expanding in the past few years. It is projected to increase…
Paget Racing Unveils New Drag Racing Bike at Dragstalgia 2024
Len Paget and team achieved a remarkable milestone with an upcycled motorcycle.
Paget Racing, led by the award-winning drag racer and Pro Stock past champion Len Paget, along with team members Reece and Kaz, has made a significant impact in the world of drag racing. The Southampton, Hampshire, England team recently showcased their innovative design and engineering prowess with a newly built drag racing bike tailored for the Old Stockers U.K.…
Extramammary Paget Disease Market Key Business Strategies by Leading Industry Pl …
Data Bridge Market Research completed a qualitative study titled "Extramammary Paget Disease Market" with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy-to-grasp full analysis. To accomplish maximum return on investment (ROI), it's very essential to be acquainted with market parameters such as brand awareness, market landscape, possible future issues, industry trends, and customer behavior where this Extramammary Paget Disease Market report comes into…
Paget's Disease Treatment Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Paget’s Disease Treatment Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Paget’s Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in…
